Ahmed Kamal
Alexandria, ALX, Egypt
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
LIMITED DIAGNOSTIC ACCURACY OF FIB-4 FOR DETECTING SIGNIFICANT LIVER FIBROSIS IN CHRONIC HEPATITIS B: A CROSS-SECTIONAL STUDY.
Journal: Arquivos de gastroenterologia
Published: June 17, 2025
Conic curve encryption and digital signature based on complex number theory for cybersecurity applications.
Journal: Scientific reports
Published: January 12, 2025
Annexin A2 as a marker for hepatocellular carcinoma detection among patients with hepatitis C virus-related liver cirrhosis after HCV treatment using directly acting antivirals.
Journal: Clinical and experimental hepatology
Published: February 28, 2024
MYELOID-DERIVED SUPPRESSOR CELLS TWO YEARS AFTER HEPATITIS C VIRUS ERADICATION USING DIRECTLY ACTING ANTIVIRALS.
Journal: Arquivos de gastroenterologia
Published: January 09, 2024
Tolloid-like 1 gene variant rs17047200, pretreatment FIB-4, ALBI and PALBI scores as predictors of hepatocellular carcinoma occurrence after directly acting antivirals.
Journal: Clinical and experimental hepatology
Published: August 24, 2022
ASSESSING PREDICTORS OF DIRECTLY ACTING ANTIVIRALS' FAILURE AS A FURTHER STEP TOWARDS MORE EFFICIENT HCV ELIMINATION PROGRAMS: IL28B (IFNL4) GENE POLYMORPHISM HAS NO ROLE WHILE HIGHER ESTIMATED CREATININE CLEARANCE IS A FORGOTTEN FACTOR.
Journal: Arquivos de gastroenterologia
Published: September 22, 2021
Association between direct-acting antiviral agents in hepatitis C virus treatment and hepatocellular carcinoma occurrence and recurrence: The endless debate.
Journal: World journal of clinical cases
Published: May 16, 2021
Relation between levels of toll-like receptors 3 and 7 and clinical profile of Child-Pugh B cirrhotic patients.
Journal: Clinical and experimental hepatology
Published: December 25, 2020
Hepatocellular carcinoma recurrence after directly acting antivirals for chronic hepatitis C: a 2-year follow-up study.
Journal: Clinical and experimental hepatology
Published: August 06, 2020
Galectin-3 is not useful for hepatocellular carcinoma surveillance in cirrhotic patients but it may be a marker of cirrhosis development.
Journal: Clinical and experimental hepatology
Published: August 05, 2020
Percutaneous radiofrequency versus microwave ablation for management of hepatocellular carcinoma: a randomized controlled trial.
Journal: Journal of gastrointestinal oncology
Published: June 12, 2019
Acute Hepatitis Caused by Genotype 4 HCV Presenting with Microangiopathic Hemolytic Anemia.
Journal: ACG case reports journal
Published: January 20, 2018
Showing 1-12 of 12
Last Updated: 09/26/2026